Form 144 Precipio For: 19 May
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Precipio Inc (PRPO)
Precipio Inc stock price live, this page displays NASDAQ PRPO stock exchange data. View the PRPO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Precipio Inc real time stock price chart below.
What Is the Precipio Inc Stock Price Today?
The Precipio Inc stock price today is 23.950.
What Is the Stock Symbol for Precipio Inc?
The stock symbol for Precipio Inc is "PRPO."
What Stock Exchange Does Precipio Inc Trade On?
Precipio Inc is listed and trades on the NASDAQ stock exchange.
Is Precipio Inc a Good Stock to Buy?
Determining whether Precipio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PRPO quote. (ISIN: US74019L6020)
What Is the Precipio Inc Stock Price Today?
The Precipio Inc stock price today is 23.950.
What Is the Stock Symbol for Precipio Inc?
The stock symbol for Precipio Inc is "PRPO."
What Stock Exchange Does Precipio Inc Trade On?
Precipio Inc is listed and trades on the NASDAQ stock exchange.
Is Precipio Inc a Good Stock to Buy?
Determining whether Precipio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PRPO quote. (ISIN: US74019L6020)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.789
25.535
52 wk Range
9.000
33.630
PRPO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.78925.535
52 wk Range
9.00033.630
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PRPO Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Precipio COO Sabet buys $487 in company stock
- Investing.com
- Precipio COO Sabet buys $505 worth of shares
- Investing.com
- Form 144 Precipio For: 19 May
- Investing.com
- Form 13G Precipio For: 10 February
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Precipio Inc Earnings Call Summary for Q1/2026
- Q1 2026 revenue rose 30% YoY to $6.71M, driven by pathology services growth to $6.0M from $4.4M prior year.
- Adjusted EBITDA swung to negative $200K from positive $960K in Q4 2025; gross margin compressed to 40% from 47%.
- Stock declined 4.21% pre-market on profitability concerns; CMS reimbursement cuts and cost pressures weighed on margins.
- Management expects cash flow normalization and margin improvement; commercial pipeline represents ~$10M in annualized revenue potential.
- Current facilities can support $45-50M in annualized revenue before requiring significant capital expenditures for expansion.
Last Updated: 05/19/2026, 07:04 PM
Read Full TranscriptEarnings
Latest Release
Mar 30, 2026
EPS / Forecast
0.29 / --
Revenue / Forecast
6.7M / --
Compare PRPO to Peers and Sector
Metrics to compare | PRPO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPRPOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −47.1x | −11.3x | −0.5x | |
PEG Ratio | −0.63 | 0.36 | 0.00 | |
Price/Book | 3.1x | 5.5x | 2.6x | |
Price / LTM Sales | 1.7x | 2.1x | 3.1x | |
Upside (Analyst Target) | - | 34.6% | 53.0% | |
Fair Value Upside | Unlock | 10.1% | 6.3% | Unlock |
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Precipio (PRPO) Stock Price Today?
The Precipio stock price today is 23.950 USD.
What Stock Exchange Does Precipio Trade On?
Precipio is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Precipio?
The stock symbol for Precipio is "PRPO."
What Is the Precipio Market Cap?
As of today, Precipio market cap is 43.370M USD.
What Is Precipio's Earnings Per Share (TTM)?
The Precipio EPS (TTM) is -0.550.
From a Technical Analysis Perspective, Is PRPO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Precipio Stock Split?
Precipio has split 4 times.
How Many Employees Does Precipio Have?
Precipio has 66 employees.
What is the current trading status of Precipio (PRPO)?
As of May 22, 2026, Precipio (PRPO) is trading at a price of 23.950 USD, with a previous close of 24.560 USD. The stock has fluctuated within a day range of 23.789 USD to 25.535 USD, while its 52-week range spans from 9.000 USD to 33.630 USD.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.